Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19
- PMID: 35966717
- PMCID: PMC9362558
- DOI: 10.1007/s11706-022-0611-y
Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19
Abstract
Microbe-related, especially viral-related pandemics have currently paralyzed the world and such pathogenesis is expected to rise in the upcoming years. Although tremendous efforts are being made to develop antiviral drugs, very limited progress has been made in this direction. The nanotheranostic approach can be a highly potential rescue to combat this pandemic. Nanoparticles (NPs) due to their high specificity and biofunctionalization ability could be utilized efficiently for prophylaxis, diagnosis and treatment against microbial infections. In this context, titanium oxide, silver, gold NPs, etc. have already been utilized against deadly viruses like influenza, Ebola, HIV, and HBV. The discovery of sophisticated nanovaccines is under investigation and of prime importance to induce reproducible and strong immune responses against difficult pathogens. This review focuses on highlighting the role of various nano-domain materials such as metallic NPs, magnetic NPs, and quantum dots in the biomedical applications to combat the deadly microbial infections. Further, it also discusses the nanovaccines those are already available for various microbial diseases or are in clinical trials. Finally, it gives a perspective on the various nanotechnologies presently employed for efficient diagnosis and therapy against disease causing microbial infections, and how advancement in this field can benefit the health sector remarkably.
Keywords: SARS-CoV-2; antimicrobial; antiviral; nanotheranostics; nanovaccine.
© Higher Education Press 2022.
Similar articles
-
Organic-Inorganic Hybrid Nanocomposites for Nanotheranostics: Special Focus on Preventing Emerging Variants of SARS-COV-2.Biomed Mater Devices. 2023 May 16:1-15. doi: 10.1007/s44174-023-00077-w. Online ahead of print. Biomed Mater Devices. 2023. PMID: 37363138 Free PMC article. Review.
-
A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19).Bull Natl Res Cent. 2021;45(1):36. doi: 10.1186/s42269-021-00487-0. Epub 2021 Feb 5. Bull Natl Res Cent. 2021. PMID: 33564223 Free PMC article. Review.
-
Recent Updates on the Role of Nanoparticles in the Treatment of Viral Diseases.Crit Rev Ther Drug Carrier Syst. 2021;38(2):75-102. doi: 10.1615/CritRevTherDrugCarrierSyst.2020034715. Crit Rev Ther Drug Carrier Syst. 2021. PMID: 33639068
-
Role of probiotics to combat viral infections with emphasis on COVID-19.Appl Microbiol Biotechnol. 2020 Oct;104(19):8089-8104. doi: 10.1007/s00253-020-10832-4. Epub 2020 Aug 19. Appl Microbiol Biotechnol. 2020. PMID: 32813065 Free PMC article. Review.
-
Nanotechnology: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1. Ont Health Technol Assess Ser. 2006. PMID: 23074489 Free PMC article.
Cited by
-
Biogenic synthesis of selenium nanoparticles from Nyctanthes arbor-tristis L. and evaluation of their antimicrobial, antioxidant and photocatalytic efficacy.Heliyon. 2024 Jun 8;10(12):e32499. doi: 10.1016/j.heliyon.2024.e32499. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39183842 Free PMC article.
-
Theranostic Diagnostics.Results Probl Cell Differ. 2024;73:551-578. doi: 10.1007/978-3-031-62036-2_22. Results Probl Cell Differ. 2024. PMID: 39242393 Review.
-
The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.Curr Top Med Chem. 2024;24(15):1327-1342. doi: 10.2174/0115680266299494240326083936. Curr Top Med Chem. 2024. PMID: 38561614 Review.
References
-
- Siafaka P I, Okur N Ü, Karantas I D, et al. Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities. Asian Journal of Pharmaceutical Sciences. 2021;16(1):24–16. doi: 10.1016/j.ajps.2020.03.003. - DOI - PMC - PubMed
-
- Rai M, Razzagh-Abyaneh M, Ingle A P, eds. Nanobiotechnology in Diagnosis, Drug Delivery and Treatment. Wiley, 2020
-
- Caster J M, Patel A N, Zhang T, et al. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2017;9(1):e1416. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous